Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201 Biotech Investing
Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection Pharmaceutical Investing
Sol-Gel Technologies Announces Collaborative Agreement for Generic Product with Perrigo Pharmaceutical Investing
HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel Genetics Investing
Isodiol International Inc. Launches ISOCare, an Innovative Platform for the Cannabis Treatment Industry Cannabis Investing News
Naturally Splendid Announces Purchase Order for National Distribution Bar Line Cannabis Investing News
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
